Development of a Clinical Decision Support Tool for Facilitating Naturalistic Decision-Making and Improving Blood Culture Utilization
开发临床决策支持工具,促进自然决策并提高血培养利用率
基本信息
- 批准号:9299167
- 负责人:
- 金额:$ 15.36万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-04-01 至 2019-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Sepsis is a frequently encountered clinical entity in pediatric intensive care units (PICUs) leading to
significant morbidity and mortality. Blood cultures (BCs), as the only way to identify blood stream infections,
represent a cornerstone of sepsis diagnosis and treatment. The overuse of BCs, however, has been shown to
result in additional laboratory tests, unnecessary antibiotic use, prolonged hospitalization, and increased
healthcare costs. Existing clinical decision support (CDS) tools for improving BC utilization focus on the use of
analytic approaches to determine the pretest probability of bloodstream infections. These CDS tools cannot
address the naturalistic and intuitive nature of clinical decision-making and, therefore, may not get adopted by
providers and improve decision quality. To improve BC utilization and reduce its negative impacts on
healthcare quality, safety, and efficiency, innovative CDS tools drawing upon the strengths of both analytical
and naturalistic decision-making are needed.
In this study, we propose to develop an electronic health record-embedded CDS tool for improving BC
utilization, which will use the strength of analytical decision-making in synthesizing large amounts of data to
facilitate naturalistic decision-making. We will apply a sociotechnical systems approach, i.e., the Systems
Engineering Initiative for Patient Safety 2.0 model, and a user-centered design method, i.e., contextual design,
to guide the development of the CDS tool, which is an iterative process including three steps:
First, we will examine individual and team cognitive work associated with obtaining a BC (Aim 1). We will
conduct shadowing with contextual inquiry and critical decision method interviews with providers to identify
their information needs and strategies used when making decisions regarding obtaining a BC.
Second, based on findings from Aim 1, we will develop the CDS tool in collaboration with providers (Aim 2).
Focus group design sessions will be conducted with providers to (1) translate findings from Aim 1 into design
requirements, (2) design and evaluate mock-ups, and (3) develop an implementation plan. Outcomes of the
focus group design sessions will be used to develop and iterative evaluate prototypes of the CDS tool.
Finally, we will implement the CDS tool in the PICU at the Johns Hopkins Hospital and assess its use and
impacts on BC utilization and patient outcomes. While qualitative observation and interview data and
computer-generated quantitative data will be collected to assess the use of the CDS tool, an interrupted time
series design will be used to assess the impacts of the CDS tool on BC utilization and patient outcomes.
This study will demonstrate that the CDS tool developed to use analytical decision-making to facilitate
naturalistic decision-making can reduce BC utilization in the PICU without influencing patient outcomes. The
CDS tool and the approach used to develop the CDS tool will be generalizable to a broader set of healthcare
issues beyond BCs.
脓毒症是儿科重症监护病房(PICU)中常见的临床实体,
严重的发病率和死亡率。血培养(BC)作为识别血流感染的唯一方法,
代表脓毒症诊断和治疗的基石。然而,过度使用BC已被证明会
导致额外的实验室检查,不必要的抗生素使用,延长住院时间,
医疗费用。用于提高BC利用率的现有临床决策支持(CDS)工具侧重于使用
分析方法,以确定血流感染的预测概率。这些CDS工具不能
解决临床决策的自然和直观性质,因此,可能不会被采用
供应商和提高决策质量。提高业务连续性的利用率,减少其对
医疗质量,安全性和效率,创新的CDS工具,借鉴了分析
和自然的决策是必要的。
在本研究中,我们建议开发一个电子健康记录嵌入CDS工具,以提高BC
利用,这将利用分析决策的力量,综合大量的数据,
促进自然决策。我们将采用社会技术系统方法,即,的系统
患者安全工程倡议2.0模型和以用户为中心的设计方法,即,情境设计,
指导CDS工具的开发,这是一个迭代过程,包括三个步骤:
首先,我们将研究与获得BC(目标1)相关的个人和团队认知工作。我们将
通过背景调查和关键决策方法与供应商进行面谈,
他们的信息需求和决策时使用的策略,获得BC。
其次,根据目标1的结果,我们将与提供者合作开发CDS工具(目标2)。
将与供应商进行焦点小组设计会议,以(1)将目标1的结果转化为设计
需求,(2)设计和评估模型,(3)制定实施计划。成果
焦点小组设计会议将用于开发和迭代评估CDS工具的原型。
最后,我们将在约翰霍普金斯医院的儿科重症监护室实施CDS工具,并评估其使用情况,
对BC利用率和患者结局的影响。虽然定性观察和访谈数据,
将收集计算机生成的定量数据,以评估CDS工具的使用,
将使用系列设计评估CDS工具对BC利用率和患者结局的影响。
这项研究将证明,CDS工具开发使用分析决策,以促进
自然主义决策可以减少PICU中BC的使用,而不会影响患者的结局。的
CDS工具和用于开发CDS工具的方法将推广到更广泛的医疗保健领域
超越BC的问题
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Anping Xie其他文献
Anping Xie的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data
- 批准号:31070748
- 批准年份:2010
- 资助金额:34.0 万元
- 项目类别:面上项目
相似海外基金
Development of a Novel Venous Thromboembolism Risk Assessment Model for Perioperative Clinical Decision Support
开发用于围手术期临床决策支持的新型静脉血栓栓塞风险评估模型
- 批准号:
10748559 - 财政年份:2023
- 资助金额:
$ 15.36万 - 项目类别:
Development of a nursing education program to acquire decision support skills for patients undergoing cancer clinical trials
制定护理教育计划,为接受癌症临床试验的患者提供决策支持技能
- 批准号:
22K17475 - 财政年份:2022
- 资助金额:
$ 15.36万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Development and Validation of an Artificial Intelligence-Based Clinical Decision Support Tool for Videofluoroscopic Swallowing Studies
用于视频透视吞咽研究的基于人工智能的临床决策支持工具的开发和验证
- 批准号:
10511906 - 财政年份:2022
- 资助金额:
$ 15.36万 - 项目类别:
Development and Validation of an Artificial Intelligence-Based Clinical Decision Support Tool for Videofluoroscopic Swallowing Studies
用于视频透视吞咽研究的基于人工智能的临床决策支持工具的开发和验证
- 批准号:
10679097 - 财政年份:2022
- 资助金额:
$ 15.36万 - 项目类别:
Development, Piloting and Dissemination of an Integrated Clinical and Social Multi-level Decision Support Platform to Address Social Determinants of Health Among Minority Populations in Baltimore City
开发、试点和传播综合临床和社会多层次决策支持平台,以解决巴尔的摩市少数民族人口健康的社会决定因素
- 批准号:
10659016 - 财政年份:2021
- 资助金额:
$ 15.36万 - 项目类别:
Development, Piloting and Dissemination of an Integrated Clinical and Social Multi-level Decision Support Platform to Address Social Determinants of Health Among Minority Populations in Baltimore City
开发、试点和传播综合临床和社会多层次决策支持平台,以解决巴尔的摩市少数民族人口健康的社会决定因素
- 批准号:
10454106 - 财政年份:2021
- 资助金额:
$ 15.36万 - 项目类别:
Decision-making in clinical drug development.
临床药物开发决策。
- 批准号:
2608270 - 财政年份:2021
- 资助金额:
$ 15.36万 - 项目类别:
Studentship
Development of End-To-End Clinical Decision Support Tools To Prevent Cardiotoxic Drug Response
开发端到端临床决策支持工具以预防心脏毒性药物反应
- 批准号:
9887500 - 财政年份:2020
- 资助金额:
$ 15.36万 - 项目类别:
Development of a multi-omic clinical decision platform to guide personalized therapy
开发多组学临床决策平台来指导个性化治疗
- 批准号:
10703682 - 财政年份:2020
- 资助金额:
$ 15.36万 - 项目类别:
Development of a multi-omic clinical decision platform to guide personalized therapy
开发多组学临床决策平台来指导个性化治疗
- 批准号:
9981389 - 财政年份:2020
- 资助金额:
$ 15.36万 - 项目类别: